"the drug must be administered at the right time point during development," he said..
standard life and aviva clash over adviser charging.
.
us opioid crisis hits indian pharma companies
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".